Dave is trading 4.2% up now at $434.50 as investors respond to a series of aggressive analyst price target increases and sustained buy/outperform ratings from major firms.
- UBS lifted its price target to $470, supported by additional upgrades from Keefe, Bruyette & Woods, Citizens, and Benchmark.
- The wave of bullish sentiment reinforces market confidence in the company's earnings momentum and monetization potential.